RC
MDT icon

Rovin Capital’s Medtronic MDT Stock Holding History

Rovin Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,846
Closed -$696K – 179
2024
Q2 		$696K Buy
8,846
+621
+8% +$50.9K 0.29% 65
2024
Q1 		$717K Buy
8,225
+339
+4% +$28.9K 0.29% 65
2023
Q4 		$650K Buy
7,886
+1,439
+22% +$110K 0.29% 62
2023
Q3 		$505K Sell
6,447
-555
-8% -$46.5K 0.23% 60
2023
Q2 		$617K Buy
7,002
+419
+6% +$36.1K 0.28% 57
2023
Q1 		$531K Buy
6,583
+8
+0.1% +$652 0.25% 62
2022
Q4 		$511K Buy
6,575
+80
+1% +$6.48K 0.25% 65
2022
Q3 		$524K Sell
6,495
-55
-0.8% -$4.94K 0.3% 54
2022
Q2 		$588K Buy
6,550
+38
+0.6% +$3.85K 0.4% 46
2022
Q1 		$723K Buy
6,512
+879
+16% +$92.9K 0.38% 39
2021
Q4 		$583K Buy
+5,633
New +$652K 0.28% 62

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rovin Capital's MDT Position: Q3 2024 in Review

Rovin Capital sold out of Medtronic (MDT) in Q3 2024, closing a stake of 8,846 shares — an estimated $696K sold.

Rovin Capital first reported a position in MDT in Q4 2021 and held it in 11 quarters. The position peaked at $723K in Q1 2022. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Rovin Capital reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Rovin Capital sold 8,846 Medtronic shares in Q3 2024, an estimated $696K.
  • Rovin Capital first reported a position in Medtronic in Q4 2021 and held it in 11 quarters.
  • Rovin Capital's Medtronic position peaked at $723K in Q1 2022.
  • 2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Rovin Capital's 13F filing for Q3 2024, filed 1 Nov 2024.